Thrivent Financial for Lutherans
PCVX icon

Thrivent Financial for Lutherans’s Vaxcyte PCVX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$683K Hold
11,742
– – ﹤0.01% 2180
2026
Q1 		$682K Hold
11,742
– – ﹤0.01% 2084
2025
Q4 		$541K Buy
11,742
+4,558
+63% +$204K ﹤0.01% 2220
2025
Q3 		$259K Sell
7,184
-15,205
-68% -$504K ﹤0.01% 2273
2025
Q2 		$728K Buy
+22,389
New +$734K ﹤0.01% 1970

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Thrivent Financial for Lutherans's PCVX Position: Q2 2026 in Review

Thrivent Financial for Lutherans held its Vaxcyte (PCVX) position steady in Q2 2026 at 11,742 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

Thrivent Financial for Lutherans first reported a position in PCVX in Q2 2025 and has held it in 5 quarters since. The position peaked at $728K in Q2 2025. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Thrivent Financial for Lutherans held 11,742 shares of Vaxcyte worth $683K as of Q2 2026.
  • Thrivent Financial for Lutherans left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #2180 holding.
  • Thrivent Financial for Lutherans first reported a position in Vaxcyte in Q2 2025 and has held it in 5 quarters since.
  • Thrivent Financial for Lutherans's Vaxcyte position peaked at $728K in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.